TCL Archive In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays April 9, 1976
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004